158 related articles for article (PubMed ID: 28521394)
1. Increased Six1 expression is associated with poor prognosis in patients with osteosarcoma.
Chao L; Liu J; Zhao D
Oncol Lett; 2017 May; 13(5):2891-2896. PubMed ID: 28521394
[TBL] [Abstract][Full Text] [Related]
2. Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma.
Lv H; Cui A; Sun F; Zhang Y; Li Y; Li L; Lin Z
Exp Mol Pathol; 2014 Aug; 97(1):74-80. PubMed ID: 24866365
[TBL] [Abstract][Full Text] [Related]
3. Six1 expression is associated with a poor prognosis in patients with glioma.
Zhang X; Xu R
Oncol Lett; 2017 Mar; 13(3):1293-1298. PubMed ID: 28454249
[TBL] [Abstract][Full Text] [Related]
4. Sineoculis homeobox homolog 1 protein is associated with breast cancer progression and survival outcome.
Jin H; Cui M; Kong J; Cui X; Lin Z; Wu Q; Liu S
Exp Mol Pathol; 2014 Oct; 97(2):247-52. PubMed ID: 25062904
[TBL] [Abstract][Full Text] [Related]
5. miR‑23b‑3p promotes the apoptosis and inhibits the proliferation and invasion of osteosarcoma cells by targeting SIX1.
Liu H; Wei W; Wang X; Guan X; Chen Q; Pu Z; Xu X; Wei A
Mol Med Rep; 2018 Dec; 18(6):5683-5692. PubMed ID: 30387818
[TBL] [Abstract][Full Text] [Related]
6.
Zhao Q; Chen G; Yang X; Wang T; Yuan S; Meng Q
Comb Chem High Throughput Screen; 2023; 26(2):330-338. PubMed ID: 35379118
[TBL] [Abstract][Full Text] [Related]
7. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
[TBL] [Abstract][Full Text] [Related]
8. The Significance of SIX1 as a Prognostic Biomarker for Survival Outcome in Various Cancer Patients: A Systematic Review and Meta-Analysis.
Zhu G; Liu Y; Zhao L; Lin Z; Piao Y
Front Oncol; 2021; 11():622331. PubMed ID: 34745930
[TBL] [Abstract][Full Text] [Related]
9. High expression of SIX1 is an independent predictor of poor prognosis in endometrial cancer.
Li W; Qin Y; Zhou R; Liu Y; Zhang G
Am J Transl Res; 2021; 13(4):2840-2848. PubMed ID: 34017447
[No Abstract] [Full Text] [Related]
10. Overexpression of SIX1 is an independent prognostic marker in stage I-III colorectal cancer.
Kahlert C; Lerbs T; Pecqueux M; Herpel E; Hoffmeister M; Jansen L; Brenner H; Chang-Claude J; Bläker H; Kloor M; Roth W; Pilarsky C; Rahbari NN; Schölch S; Bork U; Reissfelder C; Weitz J; Aust D; Koch M
Int J Cancer; 2015 Nov; 137(9):2104-13. PubMed ID: 25951369
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of Six1 correlates with progression and prognosis of prostate cancer.
Zeng J; Shi R; Cai CX; Liu XR; Song YB; Wei M; Ma WL
Cancer Cell Int; 2015; 15():63. PubMed ID: 26161040
[TBL] [Abstract][Full Text] [Related]
12. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma.
Yu C; Zhang B; Li YL; Yu XR
Biomed Pharmacother; 2018 Sep; 105():10-17. PubMed ID: 29807230
[TBL] [Abstract][Full Text] [Related]
13. [Expression of Six1 and Six4 in esophageal squamous cell carcinoma and their correlation with clinical prognosis].
Wei Q; Yu WW; Zhao KL; Fu XL; Zhu ZF; Qin GQ; Chen H; Zhang ZX; Gu YZ; Xiang JQ; Chen HQ; Du X; Sun MH
Zhonghua Bing Li Xue Za Zhi; 2013 Jul; 42(7):446-50. PubMed ID: 24246862
[TBL] [Abstract][Full Text] [Related]
14. SIX1 Predicts Poor Prognosis and Facilitates the Progression of Non-small Lung Cancer via Activating the Notch Signaling Pathway.
Huang S; Lin W; Wang L; Gao Y; Yuan X; Zhang P; Chen Y; Chu Q
J Cancer; 2022; 13(2):527-540. PubMed ID: 35069900
[No Abstract] [Full Text] [Related]
15. An Immunohistochemical Study of Stathmin 1 Expression in Osteosarcoma Shows an Association with Metastases and Poor Patient Prognosis.
Zhao C; Li H; Wang L; Sun W
Med Sci Monit; 2018 Aug; 24():6070-6078. PubMed ID: 30169496
[TBL] [Abstract][Full Text] [Related]
16. SIX1 overexpression in diffuse-type and grade III gastric tumors: Features that are associated with poor prognosis.
Emadi-Baygi M; Nikpour P; Emadi-Andani E
Adv Biomed Res; 2015; 4():139. PubMed ID: 26322287
[TBL] [Abstract][Full Text] [Related]
17. SIX1 Downregulation Suppresses Self-renewal Capacity and THY1 Expression in Hepatocellular Carcinoma and SIX1 Dominate the Survival in Liver Cancer.
Balçık-Erçin P; Aysan A; Salık N; Erciyas E
Turk J Gastroenterol; 2023 Aug; 34(8):881-889. PubMed ID: 37427884
[TBL] [Abstract][Full Text] [Related]
18. SIX1 amplification modulates stemness and tumorigenesis in breast cancer.
Guo L; Li F; Liu H; Kong D; Chen C; Sun S
J Transl Med; 2023 Nov; 21(1):866. PubMed ID: 38031089
[TBL] [Abstract][Full Text] [Related]
19. Sine Oculis Homeobox Homolog 1 Regulates Mitochondrial Apoptosis Pathway Via Caspase-7 In Gastric Cancer Cells.
Du P; Zhao J; Wang J; Liu Y; Ren H; Patel R; Hu C; Zhang W; Huang G
J Cancer; 2017; 8(4):636-645. PubMed ID: 28367243
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of long non-coding RNA MEG3 acts as a potential predictor biomarker in progression and poor prognosis of osteosarcoma.
Tian ZZ; Guo XJ; Zhao YM; Fang Y
Int J Clin Exp Pathol; 2015; 8(11):15138-42. PubMed ID: 26823857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
